These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 12817474
1. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity. Klan N, Seuter S, Schnur N, Jung M, Steinhilber D. Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474 [Abstract] [Full Text] [Related]
2. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes. Schnur N, Seuter S, Katryniok C, Rådmark O, Steinhilber D. Biochim Biophys Acta; 2007 Oct; 1771(10):1271-82. PubMed ID: 17894944 [Abstract] [Full Text] [Related]
3. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Sowa Y, Orita T, Minamikawa S, Nakano K, Mizuno T, Nomura H, Sakai T. Biochem Biophys Res Commun; 1997 Dec 08; 241(1):142-50. PubMed ID: 9405248 [Abstract] [Full Text] [Related]
4. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation. Law AY, Lai KP, Lui WC, Wan HT, Wong CK. Exp Cell Res; 2008 Oct 01; 314(16):2975-84. PubMed ID: 18652825 [Abstract] [Full Text] [Related]
5. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression. Young DA, Billingham O, Sampieri CL, Edwards DR, Clark IM. FEBS J; 2005 Apr 01; 272(8):1912-26. PubMed ID: 15819885 [Abstract] [Full Text] [Related]
6. Calcitriol upregulates open chromatin and elongation markers at functional vitamin D response elements in the distal part of the 5-lipoxygenase gene. Stoffers KL, Sorg BL, Seuter S, Rau O, Rådmark O, Steinhilber D. J Mol Biol; 2010 Jan 29; 395(4):884-96. PubMed ID: 19837082 [Abstract] [Full Text] [Related]
7. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Zhang Y, Fatima N, Dufau ML. Mol Cell Biol; 2005 Sep 29; 25(18):7929-39. PubMed ID: 16135786 [Abstract] [Full Text] [Related]
8. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation. Mulholland NM, Soeth E, Smith CL. Oncogene; 2003 Jul 31; 22(31):4807-18. PubMed ID: 12894222 [Abstract] [Full Text] [Related]
9. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells. Xiao H, Hasegawa T, Isobe K. J Cell Biochem; 1999 Jun 01; 73(3):291-302. PubMed ID: 10321829 [Abstract] [Full Text] [Related]
10. Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer. Dressel U, Renkawitz R, Baniahmad A. Anticancer Res; 2000 Jun 01; 20(2A):1017-22. PubMed ID: 10810390 [Abstract] [Full Text] [Related]
11. Inhibition of histone deacetylase activity causes cell type-specific induction of the PDGF-B promoter only in the absence of activation by its enhancer. Ullerås E, Miller SJ, Adam GI, Kanduri C, Wilcock AC, Franklin GC. Exp Cell Res; 2001 Nov 01; 270(2):188-98. PubMed ID: 11640883 [Abstract] [Full Text] [Related]
12. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. Bhakat KK, Mitra S. Carcinogenesis; 2003 Aug 01; 24(8):1337-45. PubMed ID: 12807730 [Abstract] [Full Text] [Related]
15. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. Zhao S, Venkatasubbarao K, Li S, Freeman JW. Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289 [Abstract] [Full Text] [Related]
16. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines. Kashiwagi Y, Horie K, Kanno C, Inomata M, Imamura T, Kato M, Yamamoto T, Yamashita H. Invest Ophthalmol Vis Sci; 2010 Feb 15; 51(2):679-85. PubMed ID: 19737884 [Abstract] [Full Text] [Related]